Compare Tempus AI (TEM) vs GeneDx Holdings Corp (WGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Tempus AI vs GeneDx Holdings Corp — how do they compare? Tempus AI trades at $49.01 (market cap $8.69B), while GeneDx Holdings Corp trades at $61.92 (market cap $1.80B). The key difference: Tempus AI is far larger — about 4.8× GeneDx Holdings Corp's market cap. Which is the better fit depends on your goals.
| TEM | WGS | |
|---|---|---|
Market Cap | $8.69B | $1.80B |
Sector | Broad Market / Factor | Technology |
52-Week High | $103.25 | $167.51 |
52-Week Low | $42.37 | $34.51 |
Enterprise Value | $9.37B | $1.80B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Tempus AI
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →
